Skip to content
CB

Citurgia Biochemicals

506373 BSE
Price unavailable
View as Markdown
MCP
Close 19 Oct 2026 ₹102.45 +52.68 +106% since 10 Feb 2026
Start ₹49.77

Key Fundamentals

MicrocapChemicals & PetrochemicalsChemicals

Price-based figures · EPS basis: Standalone · TTM

ROCE
—
Debt to Equity
Not meaningful: shareholders’ equity is negative
EPS (TTM)
−₹0.06
Book Value
−₹0.77
Market Cap
—
P/E (TTM)
—
P/B
—
ROE
Not meaningful: shareholders’ equity is negative
Dividend Yield
0.00%
EBITDA
−₹52.00 L
52W High
—
52W Low
—

Key Insights

No strengths listed

Weaknesses

1
  • Company has low interest coverage ratio.

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallBearish937
OscillatorsBullish234
Moving AveragesStrong Bearish703

Key readings

RSI (14)
31.92
Neutral
MACD (12,26,9)
−1.81
Bearish
SMA (50)
104.52
Bearish
SMA (200)
69.44
Bullish

As of , the latest day with price data, so these readings are not current.

Growth Rate

From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.

Revenue

Revenue growth by window
10YZero base
5YZero base
3YZero base
1YZero base
TTMZero base

Net profit

Net profit growth by window
10YLoss widened by ₹0.08 Cr
5YLoss widened by ₹0.13 Cr
3YLoss widened by ₹0.30 Cr
1YLoss widened by ₹0.32 Cr
TTMLoss widened by ₹0.30 Cr

Operating cash flow

Operating cash flow growth by window
10YOutflow widened by ₹0.05 Cr
5YOutflow narrowed by ₹0.02 Cr
3YOutflow widened by ₹0.06 Cr
1YOutflow widened by ₹0.01 Cr
TTM—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
10YNo sales
5YNo sales
3YNo sales
1YNo sales
TTMNo sales

Revenue by year

Revenue by year, ₹ crore
Mar 2017₹0.00 Cr
Mar 2018₹0.00 Cr
Mar 2019₹0.00 Cr
Mar 2020₹0.00 Cr
Mar 2021₹0.00 Cr
Mar 2022₹0.00 Cr
Mar 2023₹0.00 Cr
Mar 2024₹0.00 Cr
Mar 2025₹0.00 Cr
Mar 2026₹0.00 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2017−₹0.54 Cr
Mar 2018−₹0.55 Cr
Mar 2019−₹0.56 Cr
Mar 2020−₹0.40 Cr
Mar 2021−₹0.61 Cr
Mar 2022−₹0.40 Cr
Mar 2023−₹0.44 Cr
Mar 2024−₹0.48 Cr
Mar 2025−₹0.42 Cr
Mar 2026−₹0.74 Cr

Quarterly Results

₹ Cr
506373 quarterly results, ₹ crore
Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
0
0
0
0
0
0
0
0
0
0
0
0
0
Expenses
0.04
0.09
0.05
0.07
0.04
0.08
0.05
0.06
0.03
0.05
0.23
0.2
0.03
Operating Profit
−0.04
−0.09
−0.05
−0.07
−0.04
−0.08
−0.05
−0.06
−0.03
−0.05
−0.23
−0.2
−0.03
Other Income
0
0
0
0
0
0
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
Depreciation
0.05
0.06
0.06
0.06
0.05
0.06
0.06
0.06
0.05
0.06
0.06
0.06
0.05
PBT
−0.09
−0.15
−0.11
−0.13
−0.09
−0.14
−0.11
−0.12
−0.08
−0.11
−0.29
−0.26
−0.08
Tax %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Net Profit
−0.09
−0.15
−0.11
−0.13
−0.09
−0.14
−0.1
−0.12
−0.08
−0.11
−0.29
−0.26
−0.08
EPS (₹)
−0.01
−0.01
−0.01
−0.01
−0.01
−0.01
−0.01
−0.01
−0.01
−0.01
−0.02
−0.02
−0.01

Profit & Loss

₹ Cr
506373 profit and loss, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
0
0
0
0
0
0
0
0
0
0
0
0
0
Expenses
0.18
0.16
0.1
0.18
0.24
0.12
0.37
0.18
0.21
0.25
0.2
0.52
0.51
Operating Profit
−0.18
−0.16
−0.1
−0.18
−0.24
−0.12
−0.37
−0.18
−0.21
−0.25
−0.2
−0.52
−0.51
Other Income
0
0
0
0
0
0
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
Depreciation
0.58
0.5
0.43
0.37
0.32
0.28
0.24
0.23
0.23
0.23
0.23
0.23
0.23
PBT
−0.76
−0.66
−0.53
−0.55
−0.56
−0.4
−0.61
−0.41
−0.44
−0.48
−0.43
−0.75
−0.74
Tax %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Net Profit
−0.76
−0.66
−0.54
−0.55
−0.56
−0.4
−0.61
−0.4
−0.44
−0.48
−0.42
−0.74
−0.74
EPS (₹)
−0.06
−0.05
−0.04
−0.04
−0.04
−0.03
−0.05
−0.03
−0.03
−0.04
−0.03
−0.06
−0.06
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—

Balance Sheet

₹ Cr
506373 balance sheet, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
26.42
26.42
26.42
26.42
26.42
26.42
26.42
26.42
26.42
26.42
26.42
26.42
Reserves
−28.35
−29.01
−29.55
−30.1
−30.66
−31.06
−31.67
−32.08
−32.51
−32.99
−33.41
−34.15
Borrowings
4.49
4.5
5.15
6.45
6.48
6.48
6.49
6.49
6.55
6.77
6.83
6.89
Other Liabilities
8.59
9.67
9.93
10.05
10.13
10.13
10.36
10.6
10.73
10.84
10.92
11.31
Total Liabilities
11.15
11.58
11.95
12.82
12.37
11.97
11.6
11.43
11.19
11.04
10.76
10.47
Fixed Assets
3.66
3.16
2.73
2.36
2.04
1.76
1.52
1.3
1.07
0.85
0.62
0.4
CWIP
0
0
0
0
0
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
7.49
8.42
9.22
10.46
10.33
10.21
10.08
10.13
10.12
10.19
10.14
10.07
Total Assets
11.15
11.58
11.95
12.82
12.37
11.97
11.6
11.43
11.19
11.04
10.76
10.47

Cash Flow

₹ Cr
506373 cash flow, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
−0.03
−0.08
−0.51
−1.32
−0.19
−0.11
−0.15
−0.03
−0.07
−0.14
−0.12
−0.13
Investing
0
0
0.13
−0.07
0.02
0.06
0.15
0.01
0.04
−0.05
0.07
0.08
Financing
0
0
0.65
1.3
0.03
0
0.01
0
0.06
0.22
0.06
0.06
Net Cash Flow
−0.03
−0.08
0.27
−0.09
−0.15
−0.06
0.01
−0.01
0.02
0.03
0.01
0.01
Free Cash Flow
−0.03
−0.08
−0.51
−1.32
−0.19
−0.11
−0.15
−0.03
−0.07
−0.14
−0.12
−0.13
CFO/EBITDA
17
50
510
733
79
92
41
17
33
56
60
25

Ratios

506373 financial ratios, annual
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %
−25.94%
−29.53%
−26.97%
−22.96%
−22.36%
−19.61%
−39.61%
−39.61%
−68.22%
−145.45%
−2150%
—

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Citurgia Biochemicals insights

43 extracted metrics across FY15–FY27.

Shareholding Pattern

As of Sep 2026

  • Promoters 99.36%
  • Others 0.33%
  • Public 0.30%

No promoter shares pledged as of 14 Oct 2026

Change vs previous quarter

Documents

Frequently Asked Questions about Citurgia Biochemicals

What does Citurgia Biochemicals Ltd do?
Incorporated in 1969, Citurgia Biochemicals Ltd deals in the manufacturing and trading of citric acid.
Where is Citurgia Biochemicals Ltd (CITURGIA) listed?
Citurgia Biochemicals Ltd trades under code 506373 on the BSE.
Which sector does Citurgia Biochemicals Ltd belong to?
Citurgia Biochemicals Ltd is classified under the Commodities sector, in the Chemicals & Petrochemicals industry.

Company Information

Incorporated in 1969, Citurgia Biochemicals Ltd deals in the manufacturing and trading of citric acid.

Website citurgiabio.in
Listed 1 Mar 2006
Face Value ₹2

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/506373.md for Citurgia Biochemicals Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Chemical & Petrochemical stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month